Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SET Nuclear Oncogene (SET) Peptide

SET Reactivity: Mammalian Host: Synthetic BP, IHC, WB
Catalog No. ABIN939297

Quick Overview for SET Nuclear Oncogene (SET) Peptide (ABIN939297)

Target

SET/TAF-I (SET) (SET Nuclear Oncogene (SET))

Origin

Mammalian

Source

  • 3
  • 1
Synthetic

Application

Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
  • Peptide Type

    Synthetic

    Sequence

    IDEVQNEIDR LNEQASEEIL KVEQKYNKLR QPFFQKRSEL IAKIPNFWVT

    Characteristics

    A synthetic peptide for use as a blocking control in assays to test for specificity of SET antibody,
    Alternative Names: SET control peptide, SET antibody Blocking Peptide, Anti-SET Blocking Peptide, Set Nuclear Oncogene Blocking Peptide, 2PP2A Blocking Peptide, I2PP2A Blocking Peptide, IGAAD Blocking Peptide, PHAPII Blocking Peptide, TAF-IBETA Blocking Peptide
  • Application Notes

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Store at -20 °C long term.
  • Target

    SET/TAF-I (SET) (SET Nuclear Oncogene (SET))

    Background

    SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1.

    Molecular Weight

    32 kDa
You are here:
Chat with us!